ROQ — Roquefort Therapeutics Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- £2.63m
- £2.63m
- £0.00m
REG - Roquefort Theraptcs. - STAT-6 siRNA Demonstrates Efficacy in Immunology
AnnouncementREG - Roquefort Theraptcs. - Grant of MK Cell Patent & Licencing Update
AnnouncementREG - Roquefort Theraptcs. - Results of AGM
AnnouncementREG - Roquefort Theraptcs. - Appointment of Broker
AnnouncementREG - Roquefort Theraptcs. - Notice of Annual General Meeting
AnnouncementREG - Roquefort Theraptcs. - Issue of Convertible Loan Notes & Board Changes
AnnouncementREG - Roquefort Theraptcs. - Midkine Antibody Licencing Deal
AnnouncementREG - Roquefort Theraptcs. - Annual Report & Financial Statements - 31 Dec 2023
AnnouncementREG - Roquefort Theraptcs. - Response to Share Price Movement
AnnouncementREG - Roquefort Theraptcs. - Positive Results: Midkine mRNA and STAT-6 siRNA
AnnouncementREG - Roquefort Theraptcs. - Operations Update
AnnouncementREG - Roquefort Theraptcs. - Change of Auditor
AnnouncementREG - Roquefort Theraptcs. - Significant Mesodermal Killer Cell Milestone
AnnouncementREG - Roquefort Theraptcs. - Interim Results to 30 June 2023
AnnouncementRCS - Roquefort Theraptcs. - Investor Presentation via Investor Meet Company
AnnouncementREG - Roquefort Theraptcs. - Expansion of Patent Portfolio
AnnouncementREG - Roquefort Theraptcs. - Development of New Novel siRNA Therapeutics
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
Announcement